Agomab
@agomab.com
Agomab is translating a deep expertise in growth factor biology to pioneer and develop novel treatments that aim to resolve fibrosis, repair tissue structure and restore organ function. Combining new scientific insights with robust drug development and a long-term corporate vision, we are building a broad clinical pipeline of differentiated programs with disease modifying potential in severe organ failure and fibrotic diseases.
Agomab's Company Logos
Agomab's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#0099C9
Pacific Blue
0, 153, 201
194, 100, 39
100, 24, 0, 21
#5AC8FA
Malibu
90, 200, 250
199, 94, 67
64, 20, 0, 2
#011835
Midnight
1, 24, 53
213, 96, 11
98, 55, 0, 79
About Agomab
Agomab is a pioneering brand in the field of growth factor biology drug development. With a deep expertise in growth factor biology, Agomab is dedicated to developing groundbreaking treatments that aim to resolve fibrosis, repair tissue structure, and restore organ function. Their innovative approach combines new scientific insights with robust drug development to create a broad clinical pipeline of programs with disease-modifying potential in organ failure and fibrotic diseases.
With a commitment to patient well-being, Agomab has built a leading company supported by a unified team of experienced leaders. Led by CEO Tim Knotnerus and a talented leadership team, Agomab has raised significant investments and forged strategic partnerships. With a broad European footprint, Agomab is passionately working towards improving the lives of patients through innovation.
Contact Agomab today to learn more about their transformative work in growth factor biology drug development
Company type
Privately Held
Year founded
2017
Company size
11-50 employees
Related Brands
Tags
Clinical-stage biopharmaceutical company
Fibrosis therapeutics
TGFβ pathway inhibition
HGF/MET pathway modulation
Small molecule and antibody pipeline
